NASDAQ:OPK
Opko Health, Inc.
Opko Health, Inc.'s revenue fell 14.9% in fiscal 2025 to $606.9M while operating margin rose to −19.3%. Free cash flow was −$190.8M, −31.4% of revenue, and the diluted share count rose 8.2%.Summary generated from Opko Health, Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$606.9M
Revenue growth−14.9%
Revenue, 5-yr CAGR−15.8%
Gross margin33.9%
Operating margin−19.3%
Net margin−37.2%
ROIC−7.1%
Return on equity−17.1%
Debt / equity0.27
Free cash flow−$190.8M
FCF margin−31.4%
Share count change+8.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,775 | 1,004 | 863 | 713 | 607 |
| Operating income | 19 | −226 | −157 | −152 | −117 |
| Net income | −30 | −328 | −189 | −53 | −226 |
| Free cash flow | 6 | −120 | −44 | −208 | −191 |
Recent filings
- 8-KOther events
Oct 2, 2026 - 10-Q/AAmended quarterly report for the period ended Jun 30, 2026
Aug 28, 2026 - 10-Q/AAmended quarterly report for the period ended Mar 31, 2026
Aug 28, 2026 - 8-KEntry into a material agreement
Aug 14, 2026 - 4Insider transaction report
Jul 28, 2026 - 4Insider transaction report
Jul 28, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 27, 2026 - 8-KResults of operations and financial condition
Jul 27, 2026